TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31639060

Group type: EXPERIMENTAL
Intervention: Radiomic analysis using machine‐learning model with selected features and support vector machine classifier
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Radiomic features selected using the mRMR algorithm
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Radiomic signature consisting of two first‐order statistics and seven textural features
Number of subjects: 239
Study: 29354994

Group type: EXPERIMENTAL
Intervention: Emayaoling acupuncture technique
Number of subjects: 110

Group type: COMPARATOR
Intervention: Regular acupuncture
Number of subjects: 110
Study: 25048999

Group type: EXPERIMENTAL
Intervention: Mannitol 20% 250mL, albumin 20% 150mL and Ringer's lactate 1,100mL combined with ultrafiltration (group T)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Ringer's lactate 1,500mL in the priming reservoir (group C)
Number of subjects: 134
Study: 23182307

Group type: EXPERIMENTAL
Intervention: Rehabilitation intervention delivered by a hospice-based multidisciplinary team
Number of subjects: 41

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 41
Study: 21564123

Group type: EXPERIMENTAL
Intervention: Red color cue
Number of subjects: 33

Group type: COMPARATOR
Intervention: Chromatic or achromatic control color
Number of subjects: 33
Study: 18359255

Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation (SCS)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional medical management (CMM)
Number of subjects: 100
Study: 16521190

Group type: EXPERIMENTAL
Intervention: TJ-68
Number of subjects: 101

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 101
Study: 12672913

Group type: EXPERIMENTAL
Intervention: High meat diet (20% of energy as protein)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Low meat diet (12% of energy as protein)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: High meat diet
Number of subjects: 15

Group type: COMPARATOR
Intervention: Low meat diet
Number of subjects: 15
Study: 11099365

Group type: EXPERIMENTAL
Intervention: Oral rehydration (0.45% NaCl) equal to 50% of prior dehydration
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Intravenous infusion (0.45% NaCl) equal to 50% of prior dehydration
Number of subjects: 8

Group type: COMPARATOR
Intervention: No fluid (NF)
Number of subjects: 8
Study: 8607572

Group type: EXPERIMENTAL
Intervention: Regular diet
Number of subjects: 241

Group type: COMPARATOR
Intervention: Clear liquids
Number of subjects: 241
Study: 8659147

Group type: EXPERIMENTAL
Intervention: Burn-prone individuals
Number of subjects: 231

Group type: COMPARATOR
Intervention: Non-prone individuals
Number of subjects: 231
Study: 2908820

Group type: EXPERIMENTAL
Intervention: ICI 118,551, 50 mg t.i.d.
Number of subjects: 9

Group type: COMPARATOR
Intervention: Propranolol, 80 mg t.i.d.
Number of subjects: 9
Study: 31444314

Group type: EXPERIMENTAL
Intervention: Collagen-containing supplements (gelatin 20 g and hydrolyzed collagen 20 g)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dairy protein supplements (calcium caseinate 20 g and hydrolyzed casein 20 g)
Number of subjects: 0
Study: 28981381

Group type: EXPERIMENTAL
Intervention: n-3 fatty acids (180 mg EPA, 120 mg DHA) supplementation (1 g/day for 4 weeks)
Number of subjects: 60
Study: 27033358

Group type: COMPARATOR
Intervention: Contact-force catheter
Number of subjects: 268

Group type: COMPARATOR
Intervention: Flexible-tip catheter
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Conventional catheter
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Linear lesions and CFAEs ablation
Number of subjects: 268
Study: 24172725

Group type: EXPERIMENTAL
Intervention: Compression Stockings (CS)
Number of subjects: 10
Study: 23338256

Group type: EXPERIMENTAL
Intervention: 1% NaOCl solution
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 17% EDTA solution
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 1% NaOCl and 17% EDTA
Number of subjects: 20

Group type: COMPARATOR
Intervention: Distilled water (control)
Number of subjects: 20
Study: 19834314

Group type: EXPERIMENTAL
Intervention: Polyphenol-rich antioxidant supplement containing pomegranate extract, green tea extract, and ascorbic acid
Number of subjects: 114
Study: 18468839

Group type: EXPERIMENTAL
Intervention: Nebulized furosemide
Number of subjects: 0
Study: 16363622

Group type: EXPERIMENTAL
Intervention: 18FDG-PET
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Combination of 18FDG-PET and bone scintigraphy
Number of subjects: 44

Group type: COMPARATOR
Intervention: Bone scintigraphy
Number of subjects: 44
Study: 12398236

Group type: EXPERIMENTAL
Intervention: Post-breakfast C-peptide levels <= 0.8 nmol/l
Number of subjects: 118

Group type: COMPARATOR
Intervention: Post-breakfast C-peptide levels > 0.8 nmol/l
Number of subjects: 118

Group type: COMPARATOR
Intervention: GADA+ subjects
Number of subjects: 118

Group type: COMPARATOR
Intervention: Hypoglycemic agents and/or diet
Number of subjects: 118
Study: 9884259

Group type: EXPERIMENTAL
Intervention: Oral acyclovir (800 mg q.i.d.)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Oral ganciclovir (1000 mg t.i.d.)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Oral acyclovir vs. ganciclovir in D+R- patients
Number of subjects: 101

Group type: COMPARATOR
Intervention: Oral acyclovir vs. ganciclovir in D+R+ patients
Number of subjects: 101

Group type: COMPARATOR
Intervention: Oral acyclovir vs. ganciclovir in D-R+ patients
Number of subjects: 101
Study: 7898300

Group type: EXPERIMENTAL
Intervention: Educational intervention designed to improve probabilistic diagnostic judgments
Number of subjects: 515

Group type: COMPARATOR
Intervention: Standard lecture (control intervention)
Number of subjects: 515
Study: 2677725

Group type: EXPERIMENTAL
Intervention: Erythropoietin (600 units per kilogram of body weight) intravenously twice a week for 21 days
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo intravenously twice a week for 21 days
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Erythropoietin
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 416989

Group type: EXPERIMENTAL
Intervention: Lactobacilli preparation (Lactinex)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 30506495

Group type: EXPERIMENTAL
Intervention: CJ‐40001 (test formulation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: NESP® (reference formulation)
Number of subjects: 0
Study: 30580705

Group type: EXPERIMENTAL
Intervention: Borderzone infarcts
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Core middle cerebral artery infarcts
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Perforator infarcts
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Borderzone infarcts with impaired collateral flow
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Collateral flow assessment
Number of subjects: 101
Study: 27138652

Group type: EXPERIMENTAL
Intervention: Oritavancin 1600 mg IV over 3 hours
Number of subjects: 150

Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg oral
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 24321697

Group type: EXPERIMENTAL
Intervention: Use in negative affective situations
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Coping with negative affect as a target in treatments for marijuana dependence
Number of subjects: 87
Study: 21215605

Group type: EXPERIMENTAL
Intervention: Rye bread with added plant sterols (2g/d)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Rye bread with added plant sterols (4g/d)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (rye bread without plant sterols)
Number of subjects: 68
Study: 19854119

Group type: EXPERIMENTAL
Intervention: Breastfeeding support team intervention (hospital visits, home visits, telephone support, 24-hour pager access)
Number of subjects: 328

Group type: COMPARATOR
Intervention: Usual-care group (standard care)
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Breastfeeding support team intervention
Number of subjects: 328

Group type: COMPARATOR
Intervention: Usual-care group
Number of subjects: 328
Study: 17010149

Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing intrauterine system (LNG-IUS)
Number of subjects: 41
Study: 15567813

Group type: EXPERIMENTAL
Intervention: Intrapleural bupivacaine 0.25%
Number of subjects: 41

Group type: COMPARATOR
Intervention: Intrapleural saline
Number of subjects: 41
Study: 11814497

Group type: EXPERIMENTAL
Intervention: Vaginal Misoprostol
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: Oral Misoprostol
Number of subjects: 573

Group type: COMPARATOR
Intervention: Dinoprostone
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 573
Study: 10417864

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 14
Study: 7729296

Group type: EXPERIMENTAL
Intervention: High-dose oral magnesium therapy (30 mmol/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 40
Study: 2200300

Group type: EXPERIMENTAL
Intervention: Propofol administered at a temperature of 4 degrees C
Number of subjects: 0

Group type: COMPARATOR
Intervention: Propofol administered at standard temperature (not specified)
Number of subjects: 0
Study: 6111671

Group type: EXPERIMENTAL
Intervention: Hepatitis B surface antigen vaccine
Number of subjects: 138

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138
Study: 30519818

Group type: EXPERIMENTAL
Intervention: Metoclopramide (10 mg, three times a day for 5 days)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo (three times a day for 5 days)
Number of subjects: 112
Study: 27874176

Group type: EXPERIMENTAL
Intervention: Tai Chi training (3 weeks center-based and 12 weeks home-based, 50 minutes per session, 3 times per week)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Tai Chi training
Number of subjects: 66
Study: 25862012

Group type: EXPERIMENTAL
Intervention: Dolutegravir (DTG) 50 mg twice daily
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 25293351

Group type: EXPERIMENTAL
Intervention: DHA (400 mg daily)
Number of subjects: 261
Study: 22089249

Group type: EXPERIMENTAL
Intervention: High-sodium diet (>200 mmol of sodium per day)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Low-sodium diet (<10 mmol/d)
Number of subjects: 39
Study: 20832062

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg/day
Number of subjects: 36

Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 36
Study: 17071935

Group type: EXPERIMENTAL
Intervention: GV plus CDDP 50 mg/m(2) on days 1 and 8 (PGV arm)
Number of subjects: 433

Group type: EXPERIMENTAL
Intervention: GT plus CDDP 50 mg/m(2) on days 1 and 8 (PGT arm)
Number of subjects: 433

Group type: COMPARATOR
Intervention: GEM 1000 mg/m(2) and PTX 125 mg/m(2) on days 1 and 8 (GT arm)
Number of subjects: 433

Group type: COMPARATOR
Intervention: GEM 1000 mg/m(2) and VNR 25 mg/m(2) on days 1 and 8 (GV arm)
Number of subjects: 433
Study: 15683661

Group type: EXPERIMENTAL
Intervention: Endovascular brachytherapy (18 Gy prescribed 2 mm from the surface of centering balloons)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo (sham irradiation)
Number of subjects: 134
Study: 11872412

Group type: EXPERIMENTAL
Intervention: Thin petrolatum (0.1 cc/25 cm2)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Thick petrolatum (0.3 cc/25 cm2)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Thin salicylic acid (20%) in petrolatum
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Thick salicylic acid (20%) in petrolatum
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Sunscreen
Number of subjects: 35
Study: 10458175

Group type: EXPERIMENTAL
Intervention: Subconjunctival injection of 2.5 mg of dexamethasone disodium phosphate
Number of subjects: 50
Study: 7581970

Group type: EXPERIMENTAL
Intervention: 180 mg of Pyridostigmine (PST)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 60 mg of Pyridostigmine (PST)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 120 mg of Pyridostigmine (PST)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 100 micrograms of octreotide (SMS)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: SMS + TRH
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: PST + SMS + TRH
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 200 micrograms of TRH
Number of subjects: 6

Group type: COMPARATOR
Intervention: TRH-induced TSH response
Number of subjects: 6
Study: 2372011

Group type: EXPERIMENTAL
Intervention: Accutracker ambulatory blood pressure monitor
Number of subjects: 120
Study: 7017170

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Methyl‐chloroethyl‐cyclohexy‐nitrosourea
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Hydroxyurea
Number of subjects: 125

Group type: COMPARATOR
Intervention: All treatments
Number of subjects: 125
Study: 31678452

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Goreisan
Number of subjects: 206

Group type: COMPARATOR
Intervention: Nonadministration
Number of subjects: 206
Study: 31119717

Group type: EXPERIMENTAL
Intervention: Behavioral physical activity intervention (introductory personal training session followed by eight weekly 15-min PA behavioral coaching sessions)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Behavioral physical activity intervention
Number of subjects: 28
Study: 27901413

Group type: EXPERIMENTAL
Intervention: Overground training with stimulation (OG)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Treadmill-based training with manual assistance (TM)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Treadmill-based training with stimulation (TS)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Treadmill-based training with locomotor robotic device assistance (LR)
Number of subjects: 64
Study: 25893544

Group type: EXPERIMENTAL
Intervention: Icosapent ethyl (IPE) 4 grams/day
Number of subjects: 849

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 849
Study: 23927847

Group type: EXPERIMENTAL
Intervention: HP802‐247 (cell therapy)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 183
Study: 21181447

Group type: COMPARATOR
Intervention: HRQoL measures using SF-6D, EQ-5D, QWB-SA, HUI2, HUI3
Number of subjects: 3578

Group type: COMPARATOR
Intervention: EQ-5D
Number of subjects: 3578

Group type: COMPARATOR
Intervention: HRQoL measures
Number of subjects: 3578
Study: 19627215

Group type: EXPERIMENTAL
Intervention: BF-7
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 16914379

Group type: EXPERIMENTAL
Intervention: Monthly nurse‐led lifestyle counselling (N=31)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Conventional primary care (N=20)
Number of subjects: 51
Study: 16970865

Group type: EXPERIMENTAL
Intervention: Parent management training program (10 sessions)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 24
Study: 14632622

Group type: EXPERIMENTAL
Intervention: Therapist-selected mobilisation technique
Number of subjects: 140

Group type: COMPARATOR
Intervention: Randomly selected mobilisation technique
Number of subjects: 140
Study: 10971302

Group type: EXPERIMENTAL
Intervention: 100 mg lamotrigine once daily for 6 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: 2 g lithium gluconate anhydrous every 12 h for 5 days and in the morning of day 6
Number of subjects: 20
Study: 8971501

Group type: EXPERIMENTAL
Intervention: Alcohol (1.2 g alcohol/kg of body weight)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 8
Study: 1534831

Group type: EXPERIMENTAL
Intervention: atenolol
Number of subjects: 100

Group type: COMPARATOR
Intervention: hydrochlorothiazide and amiloride (Moduretic)
Number of subjects: 100
Study: 3898481

Group type: EXPERIMENTAL
Intervention: 150 mOsm/L hypotonic solution
Number of subjects: 0

Group type: COMPARATOR
Intervention: 300 mOsm/L isotonic solution
Number of subjects: 0
Study: 30977397

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (n = 18)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Isocaloric moderate-intensity continuous training (n = 19)
Number of subjects: 43
Study: 28526223

Group type: EXPERIMENTAL
Intervention: 5-minute cord clamping
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1-minute cord clamping
Number of subjects: 0
Study: 25525191

Group type: EXPERIMENTAL
Intervention: Memantine (20 mg)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 23069874

Group type: EXPERIMENTAL
Intervention: Rivastigmine (n = 43)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo (n = 38)
Number of subjects: 86
Study: 21240162

Group type: EXPERIMENTAL
Intervention: Inj. Aprotinin
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Tranaexaemic Acid
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Epsilon Amino Caproic Acid (EACA)
Number of subjects: 90
Study: 18971533

Group type: EXPERIMENTAL
Intervention: Nattokinase (2,000 FU/capsule) for 8 weeks
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo capsule for 8 weeks
Number of subjects: 86
Study: 17674310

Group type: EXPERIMENTAL
Intervention: Inactivated poliovirus vaccine (IPV) only
Number of subjects: 191

Group type: COMPARATOR
Intervention: Oral poliovirus vaccine (OPV) only
Number of subjects: 191
Study: 14687053

Group type: EXPERIMENTAL
Intervention: Carbon dioxide
Number of subjects: 300

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Saline plus lignocaine
Number of subjects: 300
Study: 11679461

Group type: EXPERIMENTAL
Intervention: Diabetes diagnosed by fasting plasma glucose (FPG) > or =7.0 mmol/l
Number of subjects: 5400

Group type: EXPERIMENTAL
Intervention: Diabetes diagnosed by isolated postchallenge hyperglycemia (IPH) (FPG <7.0 mmol/l and 2-h plasma glucose concentration > or =11.1 mmol/l)
Number of subjects: 5400

Group type: EXPERIMENTAL
Intervention: Diabetes diagnosed by IPH at baseline
Number of subjects: 5400

Group type: EXPERIMENTAL
Intervention: Diabetes diagnosed by FPG at baseline
Number of subjects: 5400
Study: 9815533

Group type: EXPERIMENTAL
Intervention: Broccoli supplements, 3 g/day
Number of subjects: 29

Group type: COMPARATOR
Intervention: No cruciferous vegetables (Control)
Number of subjects: 29
Study: 8267146

Group type: EXPERIMENTAL
Intervention: Clonidine group (n = 25) received 2 mL of 0.5% tetracaine (10 mg) containing clonidine (0.15 mg)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Phenylephrine group (n = 25) received 2 mL of 0.5% tetracaine (10 mg) containing phenylephrine (3 mg)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (n = 25) received 2 mL of 0.5% tetracaine (10 mg) alone
Number of subjects: 75
Study: 3300834

Group type: COMPARATOR
Intervention: Chloroquine
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: D-penicillamine
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Combination of D-penicillamine and chloroquine
Number of subjects: 72

Group type: COMPARATOR
Intervention: Chloroquine alone
Number of subjects: 72
Study: 30279267

Group type: EXPERIMENTAL
Intervention: Tocilizumab (8 mg/kg, intravenously every 2 weeks for 12 weeks)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo (intravenously every 2 weeks for 12 weeks)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27

Group type: COMPARATOR
Intervention: Tocilizumab and Placebo
Number of subjects: 27
Study: 26787799

Group type: EXPERIMENTAL
Intervention: Thermal softening of double-lumen endobronchial tubes (DLTs) in warm saline at 40°C for 10 min
Number of subjects: 140
Study: 25680893

Group type: EXPERIMENTAL
Intervention: Ticagrelor 180 mg loading dose (LD)/90 mg bid maintenance dose (MD)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 56

Group type: COMPARATOR
Intervention: Clopidogrel 600 mg LD/150 mg MD
Number of subjects: 56
Study: 23815535

Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 70

Group type: COMPARATOR
Intervention: Metoprolol succinate
Number of subjects: 70
Study: 20861128

Group type: EXPERIMENTAL
Intervention: Diabetic patients with HF
Number of subjects: 205

Group type: COMPARATOR
Intervention: Non-diabetic patients with HF
Number of subjects: 205
Study: 18647232

Group type: EXPERIMENTAL
Intervention: Dextromethorphan (DM) 120 mg day(-1) for 6 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 40
Study: 17050867

Group type: EXPERIMENTAL
Intervention: irinotecan 60 mg/m2 and docetaxel 35 mg/m2 with celecoxib 400 mg twice daily
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: irinotecan 100 mg/m2 and gemcitabine 1,000 mg/m2 with celecoxib 400 mg twice daily
Number of subjects: 133

Group type: COMPARATOR
Intervention: irinotecan 60 mg/m2 and docetaxel 35 mg/m2 without celecoxib
Number of subjects: 133

Group type: COMPARATOR
Intervention: irinotecan 100 mg/m2 and gemcitabine 1,000 mg/m2 without celecoxib
Number of subjects: 133
Study: 14639148

Group type: EXPERIMENTAL
Intervention: Levobupivacaine
Number of subjects: 70

Group type: COMPARATOR
Intervention: Ropivacaine
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Levobupivacaine and Ropivacaine
Number of subjects: 70
Study: 10958273

Group type: EXPERIMENTAL
Intervention: Intracoronary and intravenous nicorandil during PTCA (group N)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 48
Study: 8720537

Group type: EXPERIMENTAL
Intervention: 3,000 mg/day metformin
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 1,500 mg/day metformin
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 1448711

Group type: EXPERIMENTAL
Intervention: Interferon alpha-2b (10 million U by subcutaneous injection, 3 times a week for 16 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Interferon alpha-2b
Number of subjects: 20
Study: 4052301

Group type: EXPERIMENTAL
Intervention: Diazepam 0.2 mg kg‐1
Number of subjects: 7

Group type: COMPARATOR
Intervention: Saline 0.04 ml kg‐1
Number of subjects: 7
Study: 31662153

Group type: EXPERIMENTAL
Intervention: Stem cell therapy (various types including neural, haematopoietic, mesenchymal, differentiated embryonic stem cells, and induced pluripotent stem cells)
Number of subjects: 200
Study: 30350517

Group type: EXPERIMENTAL
Intervention: Group discussion among malaria control staff
Number of subjects: 24